RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 November 2010

In this Issue
  • FDA Issues Draft Guidance for When an IND Is Required
  • Live Biotherapeutic Products Clinical Trial Guidance Available
  • EMA Becomes More Transparent Regarding Document Access and Conflicts of Interest

 

© 2022 Regulatory Affairs Professionals Society.